Validation of 2-mm Tissue Microarray technology in gastric cancer. Agreement of 2-mm TMAs and full sections for Glut-1 and Hif-1 alpha

Anticancer Research

Volumn 34, Issue 7, 2014, Pages 3313-3320

  Berlth, Felix ^a   Mönig, Stefan P ^a   Schlösser, Hans A ^a   Maus, Martin ^a   Baltin, Christoph T H ^a   Urbanski, Alexander ^a   Drebber, Uta ^b   Bollschweiler, Elfriede ^a   Hölscher, Arnulf H ^a   Alakus, Hakan ^a,b,c  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Gastric cancer; Glut 1; Hif 1 alpha; Tissue microarray

Indexed keywords

GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HIF1A PROTEIN, HUMAN; PARAFFIN;

ARTICLE; CANCER SURGERY; CANCER TISSUE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPPA STATISTICS; LYMPH NODE DISSECTION; STOMACH CANCER; TISSUE INJURY; TISSUE MICROARRAY; VALIDATION STUDY; BIOPSY; CHEMISTRY; GLUT-1; HIF-1 ALPHA; HIGH THROUGHPUT SCREENING; METHODOLOGY; PATHOLOGY; STANDARD; STOMACH TUMOR; TISSUE FIXATION;

GASTRIC CANCER; GLUT-1; HIF-1 ALPHA; TISSUE MICROARRAY;

BIOPSY; GLUCOSE TRANSPORTER TYPE 1; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; PARAFFIN EMBEDDING; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; TISSUE FIXATION;

EID: 84906309228     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Camp RL, Neumeister V and Rimm DL: A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers. J Clin Oncol 26(34): 5630-5637, 2008.
2. Saggioro FP, Neder L, Stavale JN, Paixao-Becker AN, Malheiros SM, Soares FA, Pittella JE, Matias CC, Colli BO, Carlotti CG, Jr. and Franco M: Fas, FasL, and cleaved caspases 8 and 3 in glioblastomas: A tissue microarray-based study. Pathology, research and practice 210(5): 267-273, 2014.
3. Yang X, Xue L, Guo L, Wen P and Lin D: Clinicopathological and prognostic significance of a panel of Tumor Biomarkers in Lung Adenocarcinoma: a Tissue Microarray Study. Zhongguo fei ai za zhi = Chinese journal of lung cancer 17(3): 243-253, 2014.
4. Xu YC, Liu Q, Dai JQ, Yin ZQ, Tang L, Ma Y, Lin XL and Wang HX: Tissue microarray analysis of X-linked inhibitor of apoptosis (XIAP) expression in breast cancer patients. Medical oncology (Northwood, London, England) 31(3): 764, 2014.
5. Fotiades PP, Tsiambas E, Lazaris AC, Saetta AA, Karameris A, Vilaras G and Patsouris E: HER2/CHR 17 tissue microarray chromogenic in situ hybridization analysis in colon adenocarcinoma: multiple gene signals vs protein expression. Journal of BUON: official journal of the Balkan Union of Oncology 19(1): 109-114, 2014.
6. Yun JH, Roh JY, Park SH and Lee JR: CD10 Expression in Cutaneous Squamous Cell Carcinoma and Its Precursor Lesions: Evaluation Using Tissue Microarray. Annals of dermatology 25(4): 515-517, 2013.
7. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G and Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4(7): 844-847, 1998.
8. van Zwieten A: Tissue microarray technology and findings for diagnostic immunohistochemistry. Pathology 45(1): 71-79, 2013.
9. Chen B, van den Brekel MW, Buschers W, Balm AJ and van Velthuysen ML: Validation of tissue array technology in head and neck squamous cell carcinoma. Head Neck 25(11): 922-930, 2003.
10. Jourdan F, Sebbagh N, Comperat E, Mourra N, Flahault A, Olschwang S, Duval A, Hamelin R and Flejou JF: Tissue microarray technology: validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression. Virchows Arch 443(2): 115-121, 2003.
11. Gomaa W, Ke Y, Fujii H and Helliwell T: Tissue microarray of head and neck squamous carcinoma: validation of the methodology for the study of cutaneous fatty acid-binding protein, vascular endothelial growth factor, involucrin and Ki-67. Virchows Arch 447(4): 701-709, 2005.
12. Fons G, Hasibuan SM, van der Velden J and ten Kate FJ: Validation of tissue microarray technology in endometrioid cancer of the endometrium. Journal of clinical pathology 60(5): 500-503, 2007.
13. Boone J, van Hillegersberg R, van Diest PJ, Offerhaus GJ, Rinkes IH and Kate FJ: Validation of tissue microarray technology in squamous cell carcinoma of the esophagus. Virchows Arch 452(5): 507-514, 2008.
14. Gulmann C, Butler D, Kay E, Grace A and Leader M: Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarrays. Histopathology 42(1): 70-76, 2003.
15. Milanes-Yearsley M, Hammond ME, Pajak TF, Cooper JS, Chang C, Griffin T, Nelson D, Laramore G and Pilepich M: Tissue micro-array: a cost and time-effective method for correlative studies by regional and national cancer study groups. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 15(12): 1366-1373, 2002.
16. Awadelkarim KD, Arizzi C, Elamin EO, Osman I, Mekki SO, Biunno I, Barberis MC and Mariani-Costantini R: Tissue microarray (TMA) versus whole section immunohistochemistry in the assessment of ER/PR and Her-2/neu status in a breast cancer series from Sudan. The breast Journal 19(4): 446-447, 2013.
17. Urano N, Fujiwara Y, Doki Y, Tsujie M, Yamamoto H, Miyata H, Takiguchi S, Yasuda T, Yano M and Monden M: Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma. Gastric Cancer 9(1): 44-49, 2006.
18. Nakajo M, Kajiya Y, Tani A, Yoneda S, Shirahama H and Higashi M: (18)FDG PET for grading malignancy in thymic epithelial tumors: Significant differences in (18)FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: Preliminary study. Eur J Radiol, 2010.
19. Carvalho KC, Cunha IW, Rocha RM, Ayala FR, Cajaiba MM, Begnami MD, Vilela RS, Paiva GR, Andrade RG and Soares FA: GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker. Clinics (Sao Paulo) 66(6): 965-972, 2011.
20. Kundel HL and Polansky M: Measurement of observer agreement. Radiology 228(2): 303-308, 2003.
21. Schraml P, Kononen J, Bubendorf L, Moch H, Bissig H, Nocito A, Mihatsch MJ, Kallioniemi OP and Sauter G: Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 5(8): 1966-1975, 1999.
22. Kallioniemi OP, Wagner U, Kononen J and Sauter G: Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 10(7): 657-662, 2001.
23. Linderoth J, Ehinger M, Akerman M, Cavallin-Stahl E, Enblad G, Erlanson M and Jerkeman M: Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma. European journal of haematology 79(2): 146-149, 2007.
24. Pacifico MD, Grover R, Richman P, Daley F and Wilson GD: Validation of tissue microarray for the immunohistochemical profiling of melanoma. Melanoma Res 14(1): 39-42, 2004.
25. Kao SC, Lee K, Armstrong NJ, Clarke S, Vardy J, van Zandwijk N, Reid G, Burn J, McCaughan BC, Henderson DW and Klebe S: Validation of tissue microarray technology in malignant pleural mesothelioma. Pathology 43(2): 128-132, 2011.
26. Tawfik El-Mansi M and Williams AR: Validation of tissue microarray technology using cervical adenocarcinoma and its precursors as a model system. Int J Gynecol Cancer 16(3): 1225-1233, 2006.
27. Yang XR, Charette LA, Garcia-Closas M, Lissowska J, Paal E, Sidawy M, Hewitt SM, Rimm DL and Sherman ME: Construction and validation of tissue microarrays of ductal carcinoma in situ and terminal duct lobular units associated with invasive breast carcinoma. Diagn Mol Pathol 15(3): 157-161, 2006.
28. Fonseca FP, de Andrade BA, Rangel AL, Della Coletta R, Lopes MA, de Almeida OP and Vargas PA: Tissue microarray is a reliable method for immunohistochemical analysis of pleomorphic adenoma. Oral surgery, oral medicine, oral pathology and oral radiology 117(1): 81-88, 2014.
29. Oberlander M, Alkemade H, Bunger S, Ernst F, Thorns C, Braunschweig T and Habermann JK: A 'Waterfall' transferbased workflow for improved quality of tissue microarray construction and processing in breast cancer research. Pathology oncology research: POR, 2014.
30. Gottwald L, Sek P, Piekarski J, Pasz-Walczak G, Kubiak R, Szwalski J, Spych M, Suzin J, Tylinski W, Topczewska-Tylinska K and Jeziorski A: Construction of a tissue microarray with two millimeters cores of endometrioid endometrial cancer: factors affecting the quality of the recipient block. Biotechnic & histochemistry: official publication of the Biological Stain Commission, 2012.
31. Richani K, Romero R, Kim YM, Cushenberry E, Soto E, Han YM, Espinoza J and Kim CJ: Tissue microarray: an effective high-throughput method to study the placenta for clinical and research purposes. The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Ob 19(8): 509-515, 2006.
32. Kang SS, Chun YK, Hur MH, Lee HK, Kim YJ, Hong SR, Lee JH, Lee SG and Park YK: Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma. Jpn J Cancer Res 93(10): 1123-1128, 2002.
33. Sakashita M, Aoyama N, Minami R, Maekawa S, Kuroda K, Shirasaka D, Ichihara T, Kuroda Y, Maeda S and Kasuga M: Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features. Eur J Cancer 37(2): 204-209, 2001.
34. Rohwer N, Lobitz S, Daskalow K, Jons T, Vieth M, Schlag PM, Kemmner W, Wiedenmann B, Cramer T and Hocker M: HIF-1alpha determines the metastatic potential of gastric cancer cells. Br J Cancer 100(5): 772-781, 2009.
35. Oh SY, Kwon HC, Kim SH, Jang JS, Kim MC, Kim KH, Han JY, Kim CO, Kim SJ, Jeong JS and Kim HJ: Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer. BMC Cancer 8: 123, 2008.
36. Camp RL, Charette LA and Rimm DL: Validation of tissue microarray technology in breast carcinoma. Lab Invest 80(12): 1943-1949, 2000.
37. Hoos A, Urist MJ, Stojadinovic A, Mastorides S, Dudas ME, Leung DH, Kuo D, Brennan MF, Lewis JJ and Cordon-Cardo C: Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 158(4): 1245-1251, 2001.
38. Mucci NR, Akdas G, Manely S and Rubin MA: Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. Hum Pathol 31(4): 406-414, 2000.